USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cerasina GmbH

USPTO PatentsView assignee record - 6 granted patents across 0 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Cerasina ranks #39,390 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 0 technology areas.

#39,390
of 49,997 US assignees by volume
2nd percentile
by Innovation Score (14.0/100)
1.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R39390 · Foreign Corporation #39,390 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 6 grants
  • LOWER-Q #39,390/49,997
  • PHOTO-FINISH Centauri Therapeutic…
  • CPC-UNK CPC blank
  • INNOV-LOW 14.0/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2023 · 4y
  • BOOK-RICH 8/10 fields

Nearest grant-volume peer: Centauri Therapeutics Limited (GB/GB) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cerasina’s 14.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cerasina

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cerasina's Innovation Score is 14.0/100 (2nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cerasina?

Each dot is one of Cerasina’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cerasina’s own 1.0 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cerasina vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent Centauri Therapeutics Limited (GB/GB) - 6, 20.33Centauri Therapeu…Center for Deep Learning in Electronics Manufacturing - 6, 19.33Center for Deep L…Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences - 6, 9Center for Excell…Centrotherm Photovoltaics AG - 6, 13.17Centrotherm Photo…Cerebrotech Medical Systems, Inc. - 6, 9.17Cerebrotech Medic…Ceres Technologies, Inc. - 6, 13.83CeresCern Corporation - 6, 22.33CernCertus Technologies - 6, 17.67CertusCerasina GmbH - 6, 1Cerasina
Cerasina vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cerasina's grants concentrate

Cerasina GmbH is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2021. By volume, Cerasina sits between Centauri Therapeutics Limited (GB/GB) and Certus Technologies.

Cerasina's three-year grant acceleration

Cerasina GmbH shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cerasina's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cerasina holds 6 patents at rank #39,532, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cerasina

By rank, the assignees closest to #39,532 in granted patent volume.

Cerasina's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

14 2nd percentile higher than 2% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2020202120222023 1
USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Cerasina GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 33.3%
2021 1 16.7%
2022 2 33.3%
2023 1 16.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cerasina GmbH's patent record in context - here's where to go next.

  • Ranked #39,390 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cerasina GmbH against Centauri Therapeutics Limited (GB/GB), an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 14.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.